Healthcare and Life Sciences share a common purpose however serve it through entirely different technology requirements. Healthcare connects patients to care through hospitals, clinics, payers, EHR systems, and telehealth platforms. Life Sciences brings medicines to patients through drug discovery, clinical trials, manufacturing, and regulatory approval.
OpenTeQ serves both with equal depth and specialist expertise at every stage. On the healthcare side we implement EHR and EMR systems, telehealth platforms, and patient engagement tools. On the life sciences side we support the full drug development lifecycle from molecule discovery through clinical trials, regulatory submission, manufacturing, and post-market pharmacovigilance, with clinical data management as the bridge between both worlds.
Segments We Serve
OpenTeQ serves every major segment across both healthcare delivery and life sciences research and development, with solutions calibrated to each organization's regulatory environment, operational model, and technology requirements.
Acute care hospitals and integrated delivery networks delivering clinical excellence and operational efficiency across inpatient, outpatient, and post-acute care settings.
Physician practices, ambulatory care providers, and federally qualified health centers delivering accessible, high-quality outpatient care.
Commercial insurers, Medicare Advantage plans, and Medicaid managed care organizations managing cost, quality, and member experience.
Branded innovators, generics manufacturers, and specialty pharma across the full product lifecycle from drug formulation and manufacturing through clinical development, regulatory submission, commercial launch, and post-market pharmacovigilance.
Early-stage and mature biotech organizations developing cell and gene therapies, biologics, mRNA therapeutics, and rare disease treatments from target identification through IND submission and clinical development.
CROs running clinical trials and generating real-world evidence across therapeutic areas for pharmaceutical and biotech sponsors.
Class I through Class III medical device manufacturers under FDA QSR and EU MDR requirements covering connected devices, implants, diagnostics, and therapeutic equipment.
The OQ Standard governs every OpenTeQ healthcare and life sciences engagement. In an industry where technology failure carries direct consequences for patient safety, drug development timelines, and regulatory standing, the OQ Standard ensures every system is clinically sound, scientifically valid, and operationally qualified before it goes anywhere near a production environment.
Every engagement is measured against the outcomes that matter: patient safety improvements, EHR adoption rates among clinical staff, clinical trial timeline compression, regulatory submission first-cycle approval rates, CSV validation pass rates, and pharmacovigilance reporting compliance. Deployment on schedule is a baseline. Measurable improvement in patient and scientific outcomes is the standard.
With our AI-first approach, clinical decision support, drug discovery acceleration, AI-powered clinical data analysis, and pharmacovigilance signal detection using NLP are embedded into the architecture of every solution we build,governed by the clinical validation and regulatory controls that healthcare and life sciences environments require.
HIPAA, FDA 21 CFR Part 11, GAMP 5, EU Annex 11, ICH E6(R3) GCP, GxP, FDA QSR, and EU MDR are structural requirements embedded into every OpenTeQ engagement from the first design decision. Every system produces the audit-ready documentation that regulatory inspections require,built during delivery, available on demand.
OpenTeQ implements, integrates, and manages leading healthcare and life sciences technology platforms,backed by genuine clinical, scientific, and regulatory domain expertise.
From the hospital that delivers care today to the biotech lab that is discovering the medicine patients will need tomorrow, OpenTeQ serves the full spectrum of healthcare and life sciences with equal depth, equal commitment, and the same OQ Standard of delivery excellence. Whether you are modernizing an EHR system, implementing a Veeva Vault clinical suite, managing a pharmacovigilance programme, or building AI into your drug discovery pipeline,OpenTeQ is the partner who understands where your work fits in the bigger picture and how to deliver it to the standard your patients, researchers, and regulators require.
From the hospital that captures clinical trial data to the regulatory submission that presents it to the FDA, OpenTeQ is the partner that understands the full journey and can serve it end-to-end. That continuity of knowledge and accountability produces better outcomes than assembling a different specialist for every stage.
HIPAA, FDA 21 CFR Part 11, GAMP 5, EU Annex 11, ICH GCP, GxP, FDA QSR, and EU MDR are built into every OpenTeQ engagement from the architecture stage,not reviewed before go-live.
OpenTeQ's Veeva Vault practice covers the full product suite,CTMS, eTMF, QMS, Safety, Quality Docs, Promo Mats, CRM, and RIM Suite,with implementation, migration, validation, and ongoing Application Managed Services capability.
From AI-powered molecule discovery in Stage 1 through NLP-driven pharmacovigilance case processing in Stage 4, OpenTeQ applies AI-first thinking and AI-first architecture to every stage where intelligent automation can compress timelines, improve data quality, and reduce the risk of regulatory failure.
Pre-built HLS components, validated system templates, and implementation accelerators for Epic, Cerner, Veeva Vault, and Salesforce Health Cloud compress implementation timelines by 40 to 60 percent,with GxP compliance documentation and computer system validation maintained throughout.